
RevBiorevenue
Lowell, MassachusettsFounded 2014CEO Daniel McKeon
RevBio, Inc., is a clinical stage medical device company developing and commercializing TETRANITE®, a patented, synthetic, injectable, self-setting, and osteoconductive bone adhesive biomaterial.
RevBio revenue
RevBio has not published its revenue. Growjo puts it at about $10M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $10MEST | Growjo estimate |
RevBio CEO & employees
Daniel McKeon is CEO of RevBio. RevBio has 32 employees (September 2025, LinkedIn).
RevBio FAQ
What is RevBio's revenue?
Growjo estimates RevBio's revenue at about $10M a year (September 2025). The company hasn't published its own figure.
How many employees does RevBio have?
RevBio has 32 employees as of September 2025, according to LinkedIn.
Who is the CEO of RevBio?
Daniel McKeon is the CEO of RevBio.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun RevBio? Join the podcast